EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Update on the evolving landscape of pneumococcal capsule types: new discoveries and way forward

Feroze A Ganaie iD, Bernard W Beall, Jigui Yu, Mark van der Linden, Lesley McGee, Catherine Satzke iD, Sam Manna iD, Stephanie W Lo iD, Stephen D Bentley, Neil Ravenscroft, Moon H Nahm iD

Clinical Microbiology Reviews · 2025

DOI: 10.1128/cmr.00175-24 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, 2025. Verfasst von Feroze A Ganaie und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Pulmonary/Allergy/Critical Care, The University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Streptococcus pneumoniae, Bacterial Capsules, Pneumococcal Infections. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 240 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, NCI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Streptococcus pneumoniae (the “pneumococcus”) is a significant human pathogen. The key determinant of pneumococcal fitness and virulence is its ability to produce a protective polysaccharide (PS) capsule, and anti-capsule antibodies mediate serotype-specific opsonophagocytic killing of bacteria. Notably, immunization with pneumococcal conjugate vaccines (PCVs) has effectively reduced the burden of disease caused by serotypes included in vaccines but has also spurred a relative upsurge in the prevalence of non-vaccine serotypes. Recent advancements in serotyping and bioinformatics surveillance tools coupled with high-resolution analytical techniques have enabled the discovery of numerous new capsule types, thereby providing a fresh perspective on the dynamic pneumococcal landscape. This review offers insights into the current pneumococcal seroepidemiology highlighting important serotype shifts in different global regions in the PCV era. It also comprehensively summarizes newly discovered serotypes from 2007 to 2024, alongside updates on revised chemical structures and the de-novo determinations of structures for previously known serotypes. Furthermore, we spotlight emerging evidence on non-pneumococcal Mitis-group strains that express capsular PS that are serologically and biochemically related to the pneumococcal capsule types. We further discuss the implications of these recent findings on capsule nomenclature, pneumococcal carriage detection, and future PCV design. The review maps out the current status and also outlines the course for future research and vaccine strategies, ensuring a continued effective response to the evolving pneumococcal challenge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus pneumoniaeBacterial CapsulesPneumococcal InfectionsHumansPneumococcal VaccinesSerogroupSerotypingSeroepidemiologic StudiesPolysaccharides, Bacterial

Stichwörter der Autor:innen

Streptococcus pneumoniaecapsular overlapcapsular polysaccharidecapsule typescarbohydratepneumococcal conjugate vaccinesseroepidemiologyserotypes

Substanzen

Pneumococcal VaccinesPolysaccharides, Bacterial

Autor:innen und Institutionen

  • Department of Medicine, Division of Pulmonary/Allergy/Critical Care, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Eagle Global Scientific, LLC, Contractor to Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Reference Laboratory for Streptococci, Department of Medical Microbiology, University Hospital RWTH Aachen, Aachen, Germany.
  • Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Infection, Immunity and Global Health, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.
  • Department of Pediatrics, The University of Melbourne, Melbourne, Victoria, Australia.

ORCID-Profile: Feroze A Ganaie, Catherine Satzke, Sam Manna, Stephanie W Lo, Moon H Nahm

Förderung

  • Wellcome Trust
  • NCI NIH HHS
  • NIAID NIH HHS
  • NCRR NIH HHS

Zitieren

APA

Ganaie, F. A., Beall, B. W., Yu, J., van der Linden, M., McGee, L., Satzke, C., Manna, S., Lo, S. W., Bentley, S. D., Ravenscroft, N., & Nahm, M. H. (2025). Update on the evolving landscape of pneumococcal capsule types: new discoveries and way forward. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00175-24

Vancouver

Ganaie FA, Beall BW, Yu J, van der Linden M, McGee L, Satzke C, et al. Update on the evolving landscape of pneumococcal capsule types: new discoveries and way forward. Clinical Microbiology Reviews. 2025. doi:10.1128/cmr.00175-24

BibTeX
@article{Ganaie2025,
  author = {Ganaie, Feroze A and Beall, Bernard W and Yu, Jigui and van der Linden, Mark and McGee, Lesley and Satzke, Catherine and Manna, Sam and Lo, Stephanie W and Bentley, Stephen D and Ravenscroft, Neil and Nahm, Moon H},
  title = {Update on the evolving landscape of pneumococcal capsule types: new discoveries and way forward},
  journal = {Clinical Microbiology Reviews},
  year = {2025},
  doi = {10.1128/cmr.00175-24}
}
Kostenlos starten →